Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer

被引：0
|
作者：
Makoto Natsume
Takaya Shimura
Hiroyasu Iwasaki
Yusuke Okuda
Mika Kitagawa
Yasuyuki Okamoto
Kazuki Hayashi
Hiromi Kataoka
机构：
[1] Nagoya City University Graduate School of Medical Sciences,Department of Gastroenterology and Metabolism
来源：
Cancer Chemotherapy and Pharmacology | 2019年 / 83卷
关键词：
Angiogenesis; Biomarker; Gastric cancer; PlGF; Ramucirumab; VEGF;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1037 / 1046
页数：9
相关论文
共 50 条
  • [21] Evolution of predictive and prognostic biomarkers in the treatment of advanced gastric cancer
    Myer, Nicole M.
    Shitara, Kohei
    Chung, Hyun C.
    Lordick, Florian
    Kelly, Ronan J.
    Szabo, Zsolt
    Cao, Z. Alexander
    Leong, Stephen
    Ilson, David H.
    Weichert, Wilko
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (08) : 2023 - 2043
  • [22] EU-Approval for Ramucirumab (CYRAMZA®) for the Treatment of advanced Gastric Cancer after previous Chemotherapy
    Fauth, Elisabeth
    ONCOLOGY RESEARCH AND TREATMENT, 2015, 38 (1-2) : 74 - 74
  • [23] Impact of Prior Ramucirumab Use on Treatment Outcomes of Checkpoint Inhibitors in Advanced Gastric Cancer Patients
    Kim, Jinchul
    Byeon, Seonggyu
    Kim, Hyera
    Yeo, Ja Hyun
    Hong, Jung Yong
    Lee, Jeeyun
    Lim, Ho Yeong
    Kang, Won Ki
    Kim, Seung Tae
    TARGETED ONCOLOGY, 2020, 15 (02) : 203 - 209
  • [24] Prognostic biomarker in advanced gastric cancer
    Mi, Lan
    Ji, Xin
    Ji, Jiafu
    TRANSLATIONAL GASTROINTESTINAL CANCER, 2016, 5 (01) : 16 - 29
  • [25] A critical review on ramucirumab in the treatment of advanced urothelial cancer
    Vlachostergios, Panagiotis J.
    Lee, Aileen
    Thomas, Charlene
    Walsh, Ryan
    Tagawa, Scott T.
    FUTURE ONCOLOGY, 2018, 14 (11) : 1049 - 1061
  • [26] Placental growth factor in cancer
    Dewerchin, Mieke
    Carmeliet, Peter
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (11) : 1339 - 1354
  • [27] Ramucirumab for advanced gastric cancer or gastro-oesophageal junction adenocarcinoma
    Young, Kate
    Smyth, Elizabeth
    Chau, Ian
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2015, 8 (06) : 373 - 383
  • [28] Cost-effectiveness and safety of ramucirumab plus paclitaxel chemotherapy in the treatment of advanced and recurrent gastric cancer
    Kimura, Michio
    Usami, Eiseki
    Teramachi, Hitomi
    Yoshimura, Tomoaki
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (06) : 403 - 411
  • [29] Immunological impact of ramucirumab on tumor microenvironment in advanced gastric cancer.
    Togashi, Yosuke
    Tada, Yasuko
    Kotani, Daisuke
    Kawazoe, Akihito
    Doi, Toshihiko
    Nishikawa, Hiroyoshi
    Shitara, Kohei
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [30] Predictive factor of hyperprogressive disease during nivolumab in patients with advanced gastric cancer
    Sasaki, Akinori
    Nakamura, Yoshiaki
    Mishima, Saori
    Kawazoe, Akihito
    Kuboki, Yasutoshi
    Bando, Hideaki
    Kojima, Takashi
    Doi, Toshihiko
    Yoshino, Takayuki
    Shitara, Kohei
    ANNALS OF ONCOLOGY, 2018, 29
12345